Table 1 Demographics of patients according to CV events or not.
Parameter | All | No CV events (n = 19) | CV events (n = 16) | P |
---|---|---|---|---|
Age | 57 ± 14 | 52 ± 12 | 63 ± 14 | 0.017 |
Sex (male, %) | 24 (68.6%) | 12 (63.2%) | 12 (75.0%) | 0.452 |
HD vintage (years) | 6.3 ± 6.8 | 4.6 ± 4.2 | 8.2 ± 8.8 | 0.128 |
Smoking | 8 (22.9%) | 3 (15.8%) | 5 (31.3%) | 0.278 |
BMI | 24.1 ± 4.0 | 23.5 ± 4.2 | 24.8 ± 3.7 | 0.348 |
DM | 14 (40%) | 5 (26.3%) | 9 (56.3%) | 0.072 |
HTN | 25 (71.4%) | 16 (84.2%) | 9 (56.3%) | 0.068 |
Hyperlipidemia | 20 (57.1%) | 8 (42.1%) | 12 (75.0%) | 0.050 |
Medications | ||||
Aspirin | 7 (20%) | 3 (15.8%) | 4 (25.0%) | 0.497 |
Clopidogrel | 7 (20%) | 1 (5.3%) | 6 (37.5%) | 0.018 |
ACEI/ARB | 15 (42.9%) | 11 (57.9%) | 4 (25.0%) | 0.050 |
Beta blockers | 12 (34.3%) | 6 (31.6%) | 6 (37.5%) | 0.713 |
CCB | 13 (37.1%) | 8 (42.1%) | 5 (31.3%) | 0.508 |
Midodrine | 6 (17.1%) | 2 (10.5%) | 4 (25.0%) | 0.258 |
Statins | 7 (20%) | 3 (15.8%) | 4 (25.0%) | 0.497 |
OHA | 5 (14.3%) | 1 (5.3%) | 4 (25.0%) | 0.096 |
Insulin | 6 (17.1%) | 1 (5.3%) | 5 (31.3%) | 0.042 |
Laboratory | ||||
Albumin | 4.0 ± 0.3 | 4.1 ± 0.3 | 3.9 ± 0.3 | 0.118 |
BUN | 71 ± 15 | 71 ± 13 | 71 ± 17 | 0.963 |
Cr | 11.9 ± 2.2 | 12.1 ± 2.0 | 11.7 ± 2.4 | 0.573 |
K | 4.8 ± 0.7 | 5.1 ± 0.7 | 4.6 ± 0.7 | 0.042 |
Ca | 9.2 ± 0.9 | 9.0 ± 0.9 | 9.4 ± 0.9 | 0.217 |
P | 5.4 ± 1.7 | 5.5 ± 1.6 | 5.3 ± 1.9 | 0.796 |
Hb | 11.2 ± 1.2 | 11.4 ± 1.0 | 11.0 ± 1.5 | 0.311 |
HbA1c | 7.6 ± 2.0 | 6.6 ± 2.1 | 8.2 ± 1.9 | 0.189 |
PTH | 348 ± 299 | 414 ± 317 | 270 ± 264 | 0.158 |
Hemodialysis parameters | ||||
UFR | 0.7 ± 0.3 | 0.8 ± 0.4 | 0.7 ± 0.3 | 0.580 |
Duration | 3.9 ± 0.3 | 3.9 ± 0.2 | 3.9 ± 0.3 | 0.549 |
Mean Qb | 259 ± 28 | 258 ± 21 | 261 ± 35 | 0.747 |
SBP_start | 146 ± 34 | 154 ± 32 | 138 ± 34 | 0.164 |
DBP_start | 80 ± 18 | 82 ± 18 | 78 ± 20 | 0.495 |
HR_start | 76 ± 10 | 75 ± 9 | 78 ± 11 | 0.505 |
SBP_end | 143 ± 29 | 146 ± 25 | 140 ± 35 | 0.572 |
DBP_end | 86 ± 19 | 89 ± 17 | 83 ± 20 | 0.408 |
HR_end | 78 ± 15 | 78 ± 18 | 78 ± 12 | 0.926 |